NO20054700L - Anvendelse av et fibrat og orlistat for behandling av fedme - Google Patents

Anvendelse av et fibrat og orlistat for behandling av fedme

Info

Publication number
NO20054700L
NO20054700L NO20054700A NO20054700A NO20054700L NO 20054700 L NO20054700 L NO 20054700L NO 20054700 A NO20054700 A NO 20054700A NO 20054700 A NO20054700 A NO 20054700A NO 20054700 L NO20054700 L NO 20054700L
Authority
NO
Norway
Prior art keywords
fibrate
orlistat
treatment
obesity
obese patients
Prior art date
Application number
NO20054700A
Other languages
English (en)
Norwegian (no)
Inventor
Alan Dunlap Edgar
Original Assignee
Fournier Lab Ireland Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fournier Lab Ireland Ltd filed Critical Fournier Lab Ireland Ltd
Publication of NO20054700L publication Critical patent/NO20054700L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/223—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of alpha-aminoacids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Child & Adolescent Psychology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Dental Preparations (AREA)
NO20054700A 2003-03-13 2005-10-12 Anvendelse av et fibrat og orlistat for behandling av fedme NO20054700L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03290625A EP1457206A1 (fr) 2003-03-13 2003-03-13 Utilisation combinée d'un fibrate et de l'orlistat pour le traitement de l'obésité
PCT/EP2004/004010 WO2004080450A2 (fr) 2003-03-13 2004-03-12 Utilisation de fibrate et d'orlistat pour traiter l'obesite

Publications (1)

Publication Number Publication Date
NO20054700L true NO20054700L (no) 2005-10-12

Family

ID=32749013

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20054700A NO20054700L (no) 2003-03-13 2005-10-12 Anvendelse av et fibrat og orlistat for behandling av fedme

Country Status (18)

Country Link
US (1) US20070078179A1 (fr)
EP (2) EP1457206A1 (fr)
JP (1) JP4928256B2 (fr)
CN (1) CN100562313C (fr)
AT (1) ATE384520T1 (fr)
AU (1) AU2004218938B2 (fr)
BR (1) BRPI0408322A (fr)
CA (1) CA2518205C (fr)
DE (1) DE602004011486T2 (fr)
DK (1) DK1601352T3 (fr)
EA (1) EA009127B1 (fr)
ES (1) ES2300750T3 (fr)
IL (1) IL170519A (fr)
MX (1) MXPA05009718A (fr)
NO (1) NO20054700L (fr)
PT (1) PT1601352E (fr)
WO (1) WO2004080450A2 (fr)
ZA (1) ZA200507227B (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2617688C (fr) * 2007-02-22 2015-08-18 Alpex Pharma S.A. Formulations solides d'administration contenant des medicaments pour la perte de poids
EP2190303A1 (fr) * 2007-09-12 2010-06-02 Københavns Universitet Compositions et procédés pour mieux supprimer la sensation de faim et réduire la digestibilité d'une énergie non grasse et prolonger l'effet de satiété
US20120053172A1 (en) 2009-02-12 2012-03-01 Cooperatieve Mirzorg U.A. Use of a combination of diazoxide and metformin for treating obesity or obesity related disorders
DK2558105T3 (da) 2010-04-12 2020-01-27 Reata Pharmaceuticals Inc Bardoxolonmethyl til behandling af fedme
MX336980B (es) * 2010-12-21 2016-02-09 Senosiain S A De C V Lab Combinacion y composicion para el tratamiento de obesidad.
BR112015014739A2 (pt) * 2012-12-21 2017-07-11 Merck Patent Gmbh carbonato hidróxido de magnésio como excipiente em preparações farmacêuticas tendo liberação melhorada do ingrediente ativo

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1247547A (fr) * 1983-06-22 1988-12-28 Paul Hadvary Derives de leucine
CA1328881C (fr) * 1984-12-21 1994-04-26 Pierre Barbier Procede pour la fabrication d'oxetanones
TW438784B (en) * 1997-08-29 2001-06-07 Ssp Co Ltd Triazole derivative or salt thereof and pharmaceutical composition for treating mycosis containing the same
PH12000002657B1 (en) * 1999-10-12 2006-02-21 Bristol Myers Squibb Co C-aryl glucoside SGLT2 inhibitors
US6515117B2 (en) * 1999-10-12 2003-02-04 Bristol-Myers Squibb Company C-aryl glucoside SGLT2 inhibitors and method
CA2324801A1 (fr) * 1999-11-10 2001-05-10 Andrew Gordon Swick Utilisation d'inhibiteurs de secretion d'apo b et/ou de mtp et d'agents contre l'obesite
JP2003523336A (ja) * 2000-02-18 2003-08-05 メルク エンド カムパニー インコーポレーテッド 糖尿病及び脂質障害のためのアリールオキシ酢酸
EP1424070A1 (fr) * 2002-11-28 2004-06-02 Fournier Laboratories Ireland Limited Combinaison d'un agoniste de PPAR-alpha et de metformine pour la réduction du taux de triglycérides sériques

Also Published As

Publication number Publication date
JP2006520365A (ja) 2006-09-07
DK1601352T3 (da) 2008-05-13
AU2004218938B2 (en) 2009-04-09
IL170519A0 (en) 2006-10-05
CA2518205A1 (fr) 2004-09-23
CN100562313C (zh) 2009-11-25
IL170519A (en) 2010-12-30
EA009127B1 (ru) 2007-10-26
DE602004011486T2 (de) 2009-01-15
WO2004080450A2 (fr) 2004-09-23
PT1601352E (pt) 2008-04-07
WO2004080450A3 (fr) 2005-02-24
CN1826108A (zh) 2006-08-30
ES2300750T3 (es) 2008-06-16
EP1457206A1 (fr) 2004-09-15
ZA200507227B (en) 2006-11-29
EP1601352B1 (fr) 2008-01-23
EP1601352A2 (fr) 2005-12-07
EA200501259A1 (ru) 2006-02-24
JP4928256B2 (ja) 2012-05-09
AU2004218938A1 (en) 2004-09-23
BRPI0408322A (pt) 2006-03-14
MXPA05009718A (es) 2005-10-18
HK1083767A1 (en) 2006-07-14
DE602004011486D1 (de) 2008-03-13
ATE384520T1 (de) 2008-02-15
CA2518205C (fr) 2012-05-08
US20070078179A1 (en) 2007-04-05

Similar Documents

Publication Publication Date Title
DE60231295D1 (de) R und ppar modulatoren
DK1423381T3 (da) 17beta-hydroxysteroid-dehydrogenase type 3-inhibitorer til behandling af androgenafhængige sygdomme
NO20053041D0 (no) Behandling av diabetes.
NO20064124L (no) Anvendelse av metformin og orlistat for behandling eller forebygging av fedme
NO20100477L (no) Anvendelse av risendronat til fremstilling av medikamenter for behandling og prevensjon av osteoporose
DE60322582D1 (de) Oberflächenbehandlung von medizinischem gerät
NO20045065L (no) Nytt formatsalt av o-desmetyl-venlafaxin
NO20050607L (no) Fremgangsmate og innretning for tildeling av CO
DE60237823D1 (de) Medizinisches behandlungsinstrument
DE60233655D1 (de) R und retinoid x rezeptorenmodulatoren
AU2003234257A1 (en) Combination of cyclooxygenase-2 inhibitors and thalidomide for the treatment of neoplasia
NO20053042L (no) Anvendelse av spongosin (2-metoksyadenosin) for behandling av smerte, saerlig hyperalgesi.
CY1109814T1 (el) Ενας συνδυασμος που περιεχει candesartan και rosuvastatin για τη θεραπευτικη αντιμετωπιση της αρτηριοσκληρυνσης
NO20045554L (no) Fremgangsmate for behandling av diabetes
NO20072285L (no) S-mirtazapin for behandling av hetetokter
DE602004015487D1 (de) Programmiergerät für medizinisches gerät mit infrarot-kommunikation
DK1545548T3 (da) Anvendelsen af kombinationen af ciclesonid og antihistaminer til behandingen af allergisk rhinitis
NO20054700L (no) Anvendelse av et fibrat og orlistat for behandling av fedme
DK1353948T3 (da) Oplöselige biologiske analoge til bata-amyloidpeptid
DK1530462T3 (da) 1-phenyl-2-dimethylaminomethylcyclohexanforbindelser til behandling af depressionssymtomer. smerte og inkontinens
NO20055450D0 (no) Kombinasjon av et analeptisk modafinili og en antidepressiv forbindelse for behandling av depresjon
DK1569634T3 (da) Anvendelse af en PPAR-agonist og metformin til behandling af fedme
DE60325744D1 (de) Zubereitung zur behandlung des nasopharyngalen carcinom und verwendung derselben
AU2003274359A1 (en) Treatment of fluids
NO20054020D0 (no) Medisin for forhindring og behandling av arterosklerose og hypertensjon

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application